procapsgroup.com (PROC): Net earnings per share growth forecast for next year
Optimized supply chains and raw material reserves ensure the stability of Procaps Group S.A. (PROC). The projected EPS growth for the coming year confirms the success of the CDMO model through strategic alliances. Capacity expansion in the US and the launch of women's generics are driving momentum. The value of 0.00 reflects the latest metric, capturing the consensus profit forecast in the current market cycle.
Metric breakdowns and analytics for procapsgroup.com (PROC)
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- company book value details:
- company total debt and liquidity indicators:
- net income and valuation ratios data:
PROC - Net Financial Result|Future Profit Procaps Group S.A.|PROC - Company Value to Net Income|Forward P/E Multiple Procaps Group S.A.|PROC - Price to Net Income Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Procaps|PROC - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months Procaps|PROC - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months procapsgroup.com|PROC - Earnings growth in current year|Net earnings per share growth forecast for next year Procaps Group S.A.
Comprehensive company analysis:Procaps Group SA, PROC
This indicator measures market consensus expectations for earnings per share growth rates, determining fair price multiples by seeking a new yield equilibrium. By analyzing the projected change in earnings per share for the coming year, an investor can assess the resilience of Procaps Group S.A. (PROC) to currency shocks and regulatory risks in Latin America to avoid capital freezes amid unstable asset integration.
Main competitors
HLN (Haleon Group) - Earnings growth forecast for next year|Expected net earnings per share growth next year Kenvue Health KVUE|Net earnings per share growth forecast for next year Verona Pharma plc (VRNA)|MENS (jyongbio.com) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Ligand LGND|AMRX (Amneal Pharmaceuticals, Inc.) - Net earnings per share change forecast for next year|PRGO - Net earnings per share growth forecast for next year|Expected earnings per share trend next year ALVO (Alvotech Biopharmaceuticals)|Liquidia Corporation (LQDA) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year glpg.com (GLPG)|ANIP (ANI Pharmaceuticals, Inc.) - Earnings growth forecast for next year|Expected earnings per share growth for next year MannKind Corp (MNKD)|Earnings growth forecast for next year AMPH|Earnings growth forecast for next year Pacira Corp (PCRX)|Net earnings per share growth forecast for next year ARS Pharmaceuticals SPRY|TBPH (theravance.com) - Net earnings per share change forecast for next year|AQST - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year scPharmaceuticals Inc. SCPH|TECX (tectonictx.com) - Expected earnings per share growth for next year|Tonix Pharmaceuticals Holding - Expected earnings per share trend next year|SXTC (SXT Pharmaceuticals) - Earnings growth forecast for next year|EPRX - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year BioHarvest Sciences Inc. (BHST)|EXOZ (Invizyne Technologies) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Oramed Pharmaceuticals Inc. ORMP|Entera Bio Ltd (ENTX) - Expected net earnings per share growth next year|HYFT: Expected earnings per share growth for next year|ABVC - Earnings growth forecast for next year|Cumberland Pharmaceuticals Inc. (CPIX) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year QNTM (Quantum BioPharma Ltd.)|Expected earnings per share growth for next year FGEN|TELO: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Rani Therapeutics (RANI)|Consensus forecast of earnings per share growth for next year synergychc.com|Rallybio - Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year Lexaria Bioscience Corp (LEXX)|Pulmatrix Corp - Earnings growth forecast for next year|PTHL - Earnings growth forecast for next year|APM (aptorumgroup.com) - Expected earnings per share growth for next year|LYRA - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Impact BioMedical Inc|TNF Pharma - Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year cbdMD, Inc. (YCBD)|PRFX (PainReform Corp) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Altamira Therapeutics Ltd. CYTO|lipella.com (LIPO) - Expected net earnings per share growth next year|OptiNose - Earnings growth forecast for next year|Pieris Pharmaceuticals Inc (PIRS) - Expected earnings per share growth for next year|Petros (PTPI) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year QLI (Qilian International Corp)|SLRN (Acelyrin, Inc.) - Earnings growth forecast for next year|TFFP: Expected earnings per share trend next year
